TIRZEPATIDE 10MG

9Tirzepatide is a once-weekly, injectable prescription medication that works as a dual agonist, mimicking two natural gut hormones: GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide). By acting on both receptors, it is more effective at regulating blood sugar and promoting weight loss than traditional, single-agonist drug.

• Significant Weight Loss: Clinical trials (SURMOUNT-1) showed that participants on the 15 mg dose lost an average of 52 lbs (about 22.5% of body weight) over 72 weeks.
• Improved Glycemic Control: Patients with type 2 diabetes experienced improved A1C levels.
• Cardiometabolic Health: It has been associated with improvements in blood pressure, lipid levels, and reduced inflammation.

• Nausea
• Diarrhea
• Vomiting
• Constipation
• Abdominal pain/discomfort

• Boxed Warning: Tirzepatide has a boxed warning for the risk of thyroid C-cell tumors. It is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
• Pancreatitis: Severe stomach pain, which may radiate to the back, should be reported to a doctor immediately as it may indicate pancreatitis.
• Dehydration: Nausea and vomiting may lead to dehydration, which can cause kidney problems.
• Contraception: It may make oral birth control pills less effective; alternative or additional contraception is recommended.